FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym Active Entire term case insensitive SNOMED CT core module
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442103019 2 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    2 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clioquinol 10 milligram/1 milliliter and flumetasone pivalate 200 microgram/1 milliliter conventional release ear drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely chlorhexidine hydrochloride 10 milligram/1 gram and nystatin 100000 unit/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Busulfan 2mg tablets (A A H Pharmaceuticals Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Busulfan 2mg tablets (A A H Pharmaceuticals Ltd) 25 tablet Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Biperiden 2mg tablets (Special Order) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Nitisinone 2mg capsules (WEP Clinical) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Biperiden 2mg tablets 1 tablet Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Biperiden 2mg tablets (Special Order) 1 tablet Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Nitisinone 2mg capsules (WEP Clinical) 60 capsule Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Lacidipine 2mg tablets (Zentiva Pharma UK Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Lacidipine 2mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Candesartan 2mg tablets (Milpharm Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Doxazosin 2mg tablets (Milpharm Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Candesartan 2mg tablets (Milpharm Ltd) 7 tablet Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Risperidone 2mg tablets (Milpharm Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Risperidone 2mg tablets (Milpharm Ltd) 60 tablet Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Telmisartan 80mg / Hydrochlorothiazide 12.5mg tablets (Accord Healthcare Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Telmisartan 80mg / Hydrochlorothiazide 12.5mg tablets (Accord Healthcare Ltd) 28 tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Loperamide 2mg capsules (Wockhardt UK Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Loperamide 2mg capsules (Wockhardt UK Ltd) 30 capsule Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Losartan 100mg / Hydrochlorothiazide 25mg tablets (Medreich Plc) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops (Medicom Healthcare Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Brimonidine 2mg/ml eye drops (Medicom Healthcare Ltd) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Medox 50micrograms/ml / 5mg/ml eye drops (Medicom Healthcare Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Losartan 100mg / Hydrochlorothiazide 25mg tablets (Medreich Plc) 28 tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops (Medicom Healthcare Ltd) 5 ml Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Brimonidine 2mg/ml eye drops (Medicom Healthcare Ltd) 5 ml Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Medox 50micrograms/ml / 5mg/ml eye drops (Medicom Healthcare Ltd) 2.5 ml Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 250mg/125mg tablets (Consilient Health Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 500mg/125mg tablets (Consilient Health Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Dicycloverine 10mg/5ml oral solution (Morningside Healthcare Ltd) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Doxazosin 2mg tablets (Ennogen Pharma Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Crescent Pharma Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 250mg/125mg tablets (Consilient Health Ltd) 21 tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 500mg/125mg tablets (Consilient Health Ltd) 21 tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Dicycloverine 10mg/5ml oral solution (Morningside Healthcare Ltd) 120 ml Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Doxazosin 2mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Crescent Pharma Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Pioglitazone 15mg / Metformin 850mg tablets (Alliance Healthcare (Distribution) Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Pioglitazone 15mg / Metformin 850mg tablets (Alliance Healthcare (Distribution) Ltd) 56 tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Losartan 100mg / Hydrochlorothiazide 25mg tablets (Xiromed) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Xiromed) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Losartan 100mg / Hydrochlorothiazide 25mg tablets (Xiromed) 28 tablet 2 x 14 tablets Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Xiromed) 28 tablet 2 x 14 tablets Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Ceftazidime 2g powder for solution for injection vials (Tetris Pharma Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Ceftriaxone 2g powder for solution for infusion vials (Tetris Pharma Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Ceftazidime 2g powder for solution for injection vials (Tetris Pharma Ltd) 10 vial Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Ceftriaxone 2g powder for solution for infusion vials (Tetris Pharma Ltd) 10 vial Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Ceftazidime 2g powder for solution for injection vials (Stragen UK Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Ethinylestradiol 20microgram / Gestodene 75microgram tablets 21 tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Ethinylestradiol 30microgram / Gestodene 75microgram tablets 21 tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Ceftazidime 2g powder for solution for injection vials (Stragen UK Ltd) 10 vial Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    NP Thyroid 60mg (1 grain) tablets (Imported (United States)) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    NP Thyroid 60mg (1 grain) tablets (Imported (United States)) 100 tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) 1 vial Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) 10 vial Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) 1 vial Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) 1 vial Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) 10 vial Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) 10 vial Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Ceftazidime 2g powder for solution for injection vials (Fresenius Kabi Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Fresenius Kabi Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Fresenius Kabi Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Fresenius Kabi Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 500mg/100mg powder for solution for injection vials (Sandoz Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 1000mg/200mg powder for solution for injection vials (Sandoz Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Ceftazidime 2g powder for solution for injection vials (Fresenius Kabi Ltd) 1 vial Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Fresenius Kabi Ltd) 10 vial Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Fresenius Kabi Ltd) 10 vial Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Fresenius Kabi Ltd) 10 vial Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 500mg/100mg powder for solution for injection vials (Sandoz Ltd) 10 vial Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 1000mg/200mg powder for solution for injection vials (Sandoz Ltd) 10 vial Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 500mg/125mg tablets (Noumed Life Sciences Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 500mg/125mg tablets (Noumed Life Sciences Ltd) 21 tablet 3 x 7 tablets Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Ceftriaxone 2g powder for solution for injection vials (Stragen UK Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Sandoz Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Fycompa 2mg tablets (Originalis B.V.) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Valsartan 80mg / Hydrochlorothiazide 12.5mg tablets (Sandoz Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Sandoz Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Kivexa 600mg/300mg tablets (Originalis B.V.) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Ceftriaxone 2g powder for solution for injection vials (Stragen UK Ltd) 10 vial Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Sandoz Ltd) 10 vial Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Fycompa 2mg tablets (Originalis B.V.) 7 tablet Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Valsartan 80mg / Hydrochlorothiazide 12.5mg tablets (Sandoz Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Sandoz Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Kivexa 600mg/300mg tablets (Originalis B.V.) 30 tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Risperidone 2mg tablets (Torrent Pharma (UK) Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Pioglitazone 15mg / Metformin 850mg tablets (Torrent Pharma (UK) Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Tolterodine 2mg tablets (Torrent Pharma (UK) Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1

    Start Previous Page 34 of 35 End

    This concept is not in any reference sets

    Back to Start